Kaur, M., Rai, J., Bal, B. S., & Kaur, J. (2017). The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology, 3(5), 902–907. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1124